tiprankstipranks
Trending News
More News >
Xeris Pharmaceuticals (XERS)
NASDAQ:XERS
US Market
Advertisement

Xeris Pharmaceuticals (XERS) Income Statement

Compare
1,007 Followers

Xeris Pharmaceuticals Income Statement

Last quarter (Q1 2025), Xeris Pharmaceuticals's total revenue was $60.12M, an increase of 47.94% from the same quarter last year. In Q1, Xeris Pharmaceuticals's net income was $-9.22M. See Xeris Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 23Dec 23Dec 23
Total Revenue
$ 203.07M$ 163.91M$ 163.91M$ 163.91M$ 163.91M
Gross Profit
$ 166.24M$ 135.27M$ 135.27M$ 135.27M$ 135.27M
Operating Expenses
$ 199.88M$ 179.28M$ 179.28M$ 179.28M$ 179.28M
Depreciation and Amortization
$ 12.63M$ 13.16M$ 13.16M$ 13.16M$ 13.16M
EBITDA
$ -11.30M$ -23.73M$ -23.73M$ -23.73M$ -23.73M
Operating Income
$ -33.65M$ -44.01M$ -44.01M$ -44.01M$ -44.01M
Other Income/Expenses
$ -23.46M$ -19.49M$ -19.49M$ -19.49M$ -19.49M
Pretax Income
$ -57.10M$ -63.50M$ -63.50M$ -63.50M$ -63.50M
Net Income
$ -54.84M$ -62.26M$ -62.26M$ -62.26M$ -62.26M
Per Share Metrics
Basic EPS
$ -0.37$ -0.45$ -0.45$ -0.45$ -0.45
Diluted EPS
$ -0.37$ -0.45$ -0.45$ -0.45$ -0.45
Weighted Average Shares Outstanding
146.77M 137.67M 137.67M 137.67M 137.67M
Weighted Average Shares Outstanding (Diluted)
146.77M 137.67M 137.67M 137.67M 137.67M
Currency in USD

Xeris Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis